Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biomerica (BMRA) Payables (2016 - 2025)

Historic Payables for Biomerica (BMRA) over the last 15 years, with Q4 2025 value amounting to $740000.0.

  • Biomerica's Payables fell 1273.58% to $740000.0 in Q4 2025 from the same period last year, while for Nov 2025 it was $740000.0, marking a year-over-year decrease of 1273.58%. This contributed to the annual value of $672000.0 for FY2025, which is 4094.9% down from last year.
  • Per Biomerica's latest filing, its Payables stood at $740000.0 for Q4 2025, which was down 1273.58% from $681000.0 recorded in Q3 2025.
  • Biomerica's 5-year Payables high stood at $2.6 million for Q1 2022, and its period low was $387228.0 during Q1 2023.
  • For the 5-year period, Biomerica's Payables averaged around $897200.4, with its median value being $748068.0 (2021).
  • Its Payables has fluctuated over the past 5 years, first skyrocketed by 24502.26% in 2022, then plummeted by 8515.71% in 2023.
  • Quarter analysis of 5 years shows Biomerica's Payables stood at $1.6 million in 2021, then crashed by 57.61% to $670074.0 in 2022, then rose by 16.85% to $783000.0 in 2023, then rose by 8.3% to $848000.0 in 2024, then fell by 12.74% to $740000.0 in 2025.
  • Its last three reported values are $740000.0 in Q4 2025, $681000.0 for Q3 2025, and $672000.0 during Q2 2025.